Effects of Momordica charantia on insulin resistance and visceral obesity in mice on high-fat diet
- 31 August 2008
- journal article
- Published by Elsevier BV in Diabetes Research and Clinical Practice
- Vol. 81 (2), 134-143
- https://doi.org/10.1016/j.diabres.2008.04.023
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- PPARα is a key regulator of hepatic FGF21Biochemical and Biophysical Research Communications, 2007
- Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesityJCI Insight, 2000
- Peroxisome proliferator–activated receptor α mediates the adaptive response to fastingJCI Insight, 1999
- Antidiabetic Principles of Natural Medicines. III. Structure-Related Inhibitory Activity and Action Mode of Oleanolic Acid Glycosides on Hypoglycemic Activity.CHEMICAL & PHARMACEUTICAL BULLETIN, 1998
- Functional Antagonism between CCAAT/Enhancer Binding Protein-α and Peroxisome Proliferator-activated Receptor-γ on the Leptin PromoterPublished by Elsevier BV ,1997
- Anti-diabetic properties and phytochemistry of Momordica charantia L. (Cucurbitaceae)Phytomedicine, 1996
- Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factorCell, 1994
- Lipoprotein LipaseThe New England Journal of Medicine, 1989
- Impaired Pulsatile Secretion of Insulin in Relatives of Patients with Non-Insulin-Dependent DiabetesThe New England Journal of Medicine, 1988
- Impaired Glucose Tolerance as a Disorder of Insulin ActionThe New England Journal of Medicine, 1988